Wednesday, December 29, 2021 2:57:22 PM
I would hope to see the Phase 1s (+) for SCLC and Stroke in process and a PPS over $20 before looking for a Private Placement.
Terrible handling of the PRs over the last months, we should be at $10 easily with keen interest in the company's progress. Inept sequences of the PRs Killed that sadly with a severe shareholder's ass kicking.
We need strong progress in the UK with the microdose of DMT trials for Stroke, ASAP... AND a partner/sponsor like the ACS for cancer tumors, ASAP. Could happen...GLTA...
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM